Poster presentation highlighted promising pharmacology and behavioral results on lead candidate, TN-001, in preclinical studies. TN-001 is under development for both major depressive disorder (MDD) ...

Synbio International Inc. (OTC: SYIN) ("Synbio" or the "Company"), a medical technology company focused on clinically ...

DENVER, CO / / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...

Valerie Zeko emerged from 28 years of debilitating depression after participating in a groundbreaking trial at Stanford, ...

Research shows that vagus nerve stimulation can provide long-lasting benefits for patients who do not respond to conventional treatments Around 20% of adults in the United States will experience major ...

DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central n ...

A U.S. study shows that sleeping longer on weekends is linked to fewer daily depression symptoms in teens and young adults.

After a severe injury derailed her military dreams, Alexis Nelson battled through years of depression and substance abuse ...

Individuals who recognize their experiences as depression, perceive that the symptoms have serious consequences, and believe ...

Researchers suggest that, from a clinical perspective, the findings provide mechanistic insight into motivational deficits central to psychiatric disorders.

A University of Virginia alum who is the CEO of a multi-million dollar roofing and building company is facing a massive ...